WilliamLaurenceDahutMD

Hematology • Bethesda, MD

Hematologic Oncology

Physician

Join to view full profile

Dr. Dahut is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dahut's full profile

Already have an account?

Office
9000 Rockville Pike
Bethesda, MD 20892
Phone+1 301-990-8255
Is this information wrong?

Education & Training

National Capital ConsortiumResidency, Internal Medicine, 1985 - 1988
Georgetown University School of MedicineClass of 1985
National Capital ConsortiumFellowship, Hematology and Medical Oncology

Certifications & Licensure

MD State Medical License 1988 - 2024

Clinical Trials

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer Start of enrollment: 2000 Mar 01
Completed
Phase 3
2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors Start of enrollment: 2001 Sep 01
Completed
Phase 1
CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy Start of enrollment: 2002 Apr 01
Completed
Phase 1
Ketoconazole Plus Docetaxel to Treat Prostate Cancer Start of enrollment: 2002 Mar 19
Completed
Phase 1
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancer Start of enrollment: 2005 Apr 19
Completed
Phase 2
A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer Start of enrollment: 2004 Sep 01
Completed
Phase 2
AZD2171 to Treat Prostate Cancer Start of enrollment: 2006 Oct 16
Completed
Phase 2
Satraplatin and Prednisone to Treat Prostate Cancer Start of enrollment: 2008 Feb 19
Completed
Phase 2
Data Collection, Clinical Care and Interventions in CCR, NCI Start of enrollment: 2004 Jun 10
Enrolling by invitation
A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate Cancer Start of enrollment: 2009 Jul 16
Completed
Phase 2
A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) Start of enrollment: 2010 Feb 23
Completed
Phase 1, Phase 2
AMG 386 and Abiraterone for Advanced Prostate Cancer Start of enrollment: 2012 Feb 08
Completed
Phase 2
Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma Start of enrollment: 2012 Mar 01
Withdrawn
Phase 1
Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancer Start of enrollment: 2012 Sep 07
Completed
Phase 1, Phase 2
Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders Start of enrollment: 2015 Jun 01
Join now to see all

Publications & Presentations

PubMed

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition.
Scott Wilkinson, Anson T Ku, Rosina T Lis, Isaiah M King, Daniel Low, Shana Y Trostel, John R Bright, Nicholas T Terrigino, Anna Baj, John M Fenimore, Chennan Li, BaoH...> ;Medrxiv. 2024 Feb 11
Deep Learning-Based Detection and Classification of Bone Lesions on Staging Computed Tomography in Prostate Cancer: A Development Study.
Belue, M., Harmon, S., Yang, D., An, J., Gaur, S., Law, Y., Turkbey, E., Xu, Z., Tetreault, J., Lay, N., Yilmaz, E., Phelps, T., Simon, B., Lindenberg, L., Mena, E., P...> ;Academic Radiology. 2024 Jan 22
Health diplomacy in action: The cancer legacy of the Good Friday Agreement.
Lawler, M., Sullivan, R., Abou-Alfa, G., McCloskey, K., Keatley, D., Feighan, J., Dahut, W., Mulroe, E., Ladner, R., Genead, M., Lowery, M., Gulley, J., Scott, C., Lon...> ;Journal of Cancer Policy. 2023 Dec 1
3 citations
American Cancer Society's report on the status of cancer disparities in the United States, 2023.
Farhad Islami, Jordan Baeker Bispo, Hyunjung Lee, Daniel Wiese, K Robin Yabroff, Priti Bandi, Kirsten Sloan, Alpa V Patel, Elvan C Daniels, Arif H Kamal, Carmen E Guer...> ;CA. 2023 Nov 14
15 citations
Screening for lung cancer: 2023 guideline update from the American Cancer Society.
Andrew M D Wolf, Kevin C Oeffinger, Tina Ya-Chen Shih, Louise C Walter, Timothy R Church, Elizabeth T H Fontham, Elena B Elkin, Ruth D Etzioni, Carmen E Guerra, Rebecc...> ;CA. 2023 Nov 1
A tripartite approach toward ending cancer as we know it, for everyone: An American Cancer Society perspective.
William L Dahut, Arif H Kamal, Lisa A Lacasse, Kathryn M Sanders, Karen E Knudsen> ;Journal of Surgical Oncology. 2023 Nov 1
1 citations
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide.
Shruti U Gandhy, Fatima H Karzai, Marijo Bilusic, Sheri McMahon, Lisa M Cordes, Jennifer Marte, Amy J Weisman, Timothy G Perk, Liza Lindenberg, Esther Mena, Baris Turk...> ;European Urology Oncology. 2023 Oct 17
The future of cancer care at home: Findings from an American Cancer Society summit.
Arif H Kamal, Paul P Thienprayoon, Marco H M Janssen, Lisa A Lacasse, William L Dahut, Justin E Bekelman> ;CA. 2023 May 24
1 citations
Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.
Ravi A Madan, Marijo Bilusic, Mark N Stein, Renee N Donahue, Philip M Arlen, Fatima Karzai, Elizabeth Plimack, Yu-Ning Wong, Daniel M Geynisman, Matthew Zibelman, Tina...> ;The Oncologist. 2023 Jul 5
1 citations
Avelumab in Men With Metastatic Castration-Resistant Prostate Cancer, Enriched for Patients Treated Previously With a Therapeutic Cancer Vaccine.
Ravi A Madan, Jason M Redman, Fatima Karzai, William L Dahut, Lisa Cordes, Farhad Fakhrejahani, Tuyen Vu, Nadeem Sheikh, Jeffrey Schlom, James L Gulley> ;Journal of Immunotherapy. 2023 May 1
7 citations
Testing: Time to Put Patient Safety First.
Sharyn D Baker, Susan E Bates, Gabriel A Brooks, William L Dahut, Robert B Diasio, Wafik S El-Deiry, William E Evans, William D Figg, Dan L Hertz, J Kevin Hicks, Sunee...> ;Journal of Clinical Oncology. 2023 May 20
6 citations
Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome.
Gal Dinstag, Eldad D Shulman, Efrat Elis, Doreen S Ben-Zvi, Omer Tirosh, Eden Maimon, Isaac Meilijson, Emmanuel Elalouf, Boris Temkin, Philipp Vitkovsky, Eyal Schiff, ...> ;Med. 2023 Jan 13
19 citations
Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA.
Elizabeth J Schafer, Ahmedin Jemal, Daniel Wiese, Hyuna Sung, Tyler B Kratzer, Farhad Islami, William L Dahut, Karen E Knudsen> ;European Urology. 2023 Jul 1
2 citations
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance.
J Kellogg Parsons, Peter A Pinto, Christian P Pavlovich, Edward Uchio, Mike N Nguyen, Hyung L Kim, James L Gulley, Houssein Abdul Sater, Christina Jamieson, Chiu-Hsieh...> ;European Urology Focus. 2023 May 1
2 citations
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutam...
Keith T Schmidt, Fatima Karzai, Marijo Bilusic, Lisa M Cordes, Cindy H Chau, Cody J Peer, Susan Wroblewski, Alwin D R Huitema, Jan H M Schellens, James L Gulley, Willi...> ;The Oncologist. 2022 Sep 2
6 citations
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer.
Adam G Sowalsky, Ines Figueiredo, Rosina T Lis, Ilsa Coleman, Bora Gurel, Denisa Bogdan, Wei Yuan, Joshua W Russo, John R Bright, Nichelle C Whitlock, Shana Y Trostel,...> ;Clinical Cancer Research. 2022 Aug 15
11 citations
A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1).
Marijo Bilusic, Nicole J Toney, Renee N Donahue, Susan Wroblewski, Matthew Zibelman, Pooja Ghatalia, Eric A Ross, Fatima Karzai, Ravi A Madan, William L Dahut, James L...> ;Prostate Cancer and Prostatic Diseases. 2022 Apr 1
Assessment of Aortoiliac Atherosclerotic Plaque on CT in Prostate Cancer Patients Undergoing Treatment.
Sungwon Lee, Daniel C Elton, James L Gulley, Perry J Pickhardt, William L Dahut, Ravi A Madan, Peter A Pinto, Deborah E Citrin, Ronald M Summers> ;Tomography. 2022 Mar 1
9 citations
A comparison of 18F-DCFPyL, 18F-NaF and 18F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.
Aloÿse Fourquet, Adrian Rosenberg, Esther Mena, Joanna J. Shih, Baris Turkbey, Maxime Blain, Ethan Bergvall, Frank I. Lin, Stephen Adler, Ilhan Lim, Ravi A. Madan, Fat...> ;Journal of Nuclear Medicine. 2021 Sep 2
Editorial Comment.
Peter Choyke, William Dahut> ;The Journal of Urology. 2021 Jul 1
Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair Mutations.
Vincent Chau, Ravi A. Madan, Marijo Bilusic, Helen Owens, Lisa M. Cordes, Jennifer L. Marte, James L. Gulley, Jung-Min Lee, William L. Dahut, Fatima Karzai> ;Clinical Genitourinary Cancer. 2021 May 17
40 citations
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.
, , , , , , , , , , , , , , , , , , , , , , , , , , > ;European Urology. 2021 Mar 27
Creating opportunities in cancer research
William L. Dahut, Glenn Merlino, Tom Misteli> ;Nature Cancer. 2021 Mar 24
1 citations
Pilot study of gadoxetate disodium-enhanced mri for localized and metastatic prostate cancers.
Sarah E Lochrin, Baris Turkbey, Billel Gasmi, Keith T. Schmidt, Jonathan D. Strope, Cindy H. Chau, Tristan M. Sissung, Douglas K. Price, Lisa M. Cordes, Suzana Markolo...> ;Scientific Reports. 2021 Mar 11
10 citations
Clinical and immunologic impact of short-course enzalutamide alone and with immunotherapy in non-metastatic castration sensitive prostate cancer.
Ravi A. Madan, Fatima Karzai, Renee N. Donahue, Munjid Al-Harthy, Marijo Bilusic, Inger I Rosner, Harpreet Singh, Philip M. Arlen, Marc R. Theoret, Jennifer L. Marte, ...> ;Journal for Immunotherapy of Cancer. 2021 Mar 1
Join now to see all

Press Mentions

As Colorectal Cancer Rises Among Younger Adults, Some Seek Colonoscopies EarlierMay 26th, 2023
Severe Asthma and Lung Cancer: What’s the Link?May 22nd, 2023
Amid Cancer Drug Shortages, Some Michigan Doctors Are Forced to RationMay 19th, 2023
Join now to see all

Grant Support

The Evaluation Of Novel Therapeutics For Genitourinary MalignanciesNational Cancer Institute2010–2011
The Evaluation Of Novel Therapeutics For Genitourinary MalignanciesDivision Of Clinical Sciences - Nci2009
The Evaluation Of Novel Therapeutics For Genitourinary MalignanciesNational Cancer Institute2007–2008
Evaluation Of Novel Therapeutics For Genitourinary MaligDivision Of Clinical Sciences - Nci2003
The Evaluation Of Novel Therapeutics For Genitourinary MDivision Of Clinical Sciences - Nci2002
Evaluation Of Therapeutics For Genitourinary MalignancyDivision Of Clinical Sciences - Nci2001
Novel Therapeutics For Genitourinary MalignanciesDivision Of Clinical Sciences - Nci2000

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

WilliamLaurenceDahutMD

Dr. Dahut is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Grant Support

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.